Local recommendations (Cardiovascular)
Diuretics
Recommendation | Approval date | Review date |
Hydrochlorothiazide EKPG EKHUFT | February 2019 | February 2022 |
Metolazone (Xaqua®) Position Statement | June 2024 | June 2026 |
Metolazone (Xaqua®) Information for Patients | June 2024 | June 2026 |
Hypertension and Heart Failure
Recommendation | Approval date | Review date |
EKPG Recommendation - Sacubitril Valsartan | November 2016 | November 2019 |
Sacubitril Valsartan GP letter | June 2016 | April 2021 |
Sacubitril valsartan GP summary | June 2016 | April 2021 |
Midodrine prescribing information sheet (V2) | April 2016 | April 2021 |
B195. Doxazosin MR 2.0 | January 2018 | January 2021 |
K&M Implementation of NICE TA’s – SGLT2 inhibitors (Dapagliflozin & Empagliflozin) in the treatment of chronic heart failure | December 2023 | December 2025 |
Nitrates, calcium-channel blockers, and other antianginal drugs
Recommendation | Approval date | Review date |
Chronic Heart Failure -ECK Ivabradine NICE TA 267 | July 2015 | April 2021 |
Lipid modifying drugs
Recommendation | Approval date | Review date |
Alirocumab & Evoculumab, GP update on Implementation of NICE TAs 393 & 394 | November 2017 | November 2020 |
EKPG Recommendation - Evolocumab and alirocumab for hypercholesterolaemia | April 2017 | April 2020 |
Implementation Guidance for NICE TA 694 - Bempedoic Acid | September 2021 | September 2022 |
Summary of national guidance for lipid management for primary and secondary prevention of CVD | April 2022 | April 2023 |
Kent & Medway ICB Position Statement for Prescribing Inclisiran | July 2023 | July 2025 |
Antithrombotic drugs
Recommendation | Approval date | Review date |
LMWH Prescribing Pathways in East Kent | February 2024 | February 2026 |
Enoxaparin pre surgery EKPG recommendation | July 2015 | April 2021 |
Ticagrelor for the prevention of atherothrombotic events in adult patients with ACS, EKPG | August 2013 | April 2021 |
EKPG Recommendation - Argatroban for type 2 heparin-induced thrombocytopenia | March 2017 | March 2020 |
Factsheet - Inhixa (Enoxaparin) | October 2020 | October 2022 |
See NICE guidance for choice of anticoagulation in AF: https://www.nice.org.uk/guidance/ng196 Please consider choice of anticoagulant in light of COVID-19 with reference to national guidance (here) and MHRA advice (here). |
December 2021 | December 2023 |
Kent and Medway ICB Position Statement and Risk Mitigation Principles for Anticoagulant Prescribing in nvAF | April 2024 | April 2026 |
EKPG Recommendation - NOACs DVT PE Treatment Document due for review. Since this document was published, a reversal agent for rivaroxaban and apixaban has become available. |
August 2018 | August 2021 |
General (Cardio)
Recommendation | Approval date | Review date |
Rituximab for the treatment of immune thrombocytopenic purpura, EKPG Recommendation | December 2015 | April 2021 |
Dapagliflozin in CKD guide | June 2022 | June 2024 |